Laborie Acquires the JADA® System from Organon
January 28, 2026
Laborie Medical Technologies has completed the acquisition of the JADA® System and the team behind it from Organon in a transaction announced in late January 2026. The deal — part of Organon’s divestiture program (previously disclosed as up to $465 million) — brings more than 90 employees and an FDA-cleared device for rapid control of postpartum hemorrhage into Laborie’s obstetrics portfolio to expand the company’s maternal health capabilities.
- Buyers
- Laborie Medical Technologies
- Targets
- JADA System
- Sellers
- Organon
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Organon Acquires Alydia Health
June 16, 2021
Medical Devices
Organon completed its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing postpartum hemorrhage, for total consideration of $240 million (including up to $25 million in contingent milestones). The deal expands Organon’s portfolio into medical devices and leverages its global commercial footprint to broaden access to Alydia’s Jada System for maternal hemorrhage worldwide.
-
Laborie Medical Technologies Acquires Pelvalon
October 13, 2021
Medical Devices
Laborie Medical Technologies Corp., a specialist medical technology company headquartered in Portsmouth, New Hampshire, has acquired Pelvalon, Inc., a Redwood City, California-based medical device company. Pelvalon’s Eclipse System is an FDA-cleared, non-surgical, patient-controlled device for women with fecal incontinence; the acquisition expands Laborie’s portfolio in pelvic floor and women’s health therapies.
-
Laborie Medical Technologies Acquires Urotronic
October 27, 2023
Medical Devices
Laborie Medical Technologies has completed the acquisition of Urotronic, a Plymouth, Minnesota-based developer of the Optilume drug‑coated balloon technology for interventional urology. The deal includes an upfront cash payment (net $232 million to Laborie considering its prior minority stake) and up to $345 million in milestone payments, and brings Urotronic and its employees fully into Laborie to expand Laborie's interventional urology product portfolio globally.
-
Laborie Medical Technologies Acquires Novonate (LifeBubble)
February 14, 2023
Medical Devices
Laborie Medical Technologies has acquired Novonate, Inc. and its LifeBubble umbilical catheter securement system to expand Laborie's obstetrics, gynecology and neonatal product portfolio. Novonate, founded in 2017 and based in South San Francisco, developed LifeBubble to improve safety and securement of umbilical catheters in NICUs.
-
Marketlab Acquires Assets of Medi‑Tech International Corporation
September 12, 2023
Medical Devices
Marketlab, a family-owned manufacturer of specialty healthcare products based in Caledonia, Michigan, has acquired the assets of Medi‑Tech International Corporation, a Brooklyn, New York‑based manufacturer of wound care, labor‑and‑delivery, and patient safety products. The acquisition expands Marketlab’s medical‑surgical and laboratory product portfolio and brings additional products, distribution partnerships, and GPO contracts into its offering to better serve IDNs and other healthcare customers.
-
Johnson & Johnson MedTech Acquires Laminar, Inc.
November 30, 2023
Medical Devices
Johnson & Johnson MedTech has completed the acquisition of Laminar, Inc., a privately held medical device developer focused on eliminating the left atrial appendage (LAA) in patients with non‑valvular atrial fibrillation, for $400 million upfront plus potential clinical and regulatory milestone payments. Laminar will join Johnson & Johnson MedTech’s Biosense Webster business to expand the company’s electrophysiology and interventional cardiology portfolio and accelerate development and commercialization of Laminar’s rotational LAA elimination technology.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.